globenewswire health1 min read
saveTiziana Life Sciences CEO Ivor Elrifi boosts stake, buying 321,423 shares at $1 each
read at globenewswire health ↗DealPositive
Tiziana Life Sciences announced that its chief executive officer, Ivor Elrifi, purchased 321,423 common shares of the company on NASDAQ at $1.00 per share.
The purchase raises his total holding to 4,793,684 shares, indicating strong personal confidence in the company's prospects.
The company is developing intranasal foralumab, a fully human anti‑CD3 monoclonal antibody being evaluated in an expanded access program and a Phase 2a trial for non‑active secondary progressive multiple sclerosis.
source
This writeup was produced by pharmadog from original reporting by globenewswire health.
Original headline: “Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer”
read at globenewswire health ↗339 words · retrieved Aug 7
comments(0)
5-min edit window · permanent after that